window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : April 25, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Technology and platforms

  • CDMOs & Manufacturing,Global health,Regulatory Affairs,Research & Development,Supply Chain & Logistics,Technology and platforms

    Axplora expands Vizag API capacity and confirms FDA inspection success at Indian sites

    Axplora has announced a €6.5 million investment at its Vizag [...]

    August 6, 2025
  • Clinical Trials,Digital Health,Precision medicine,Research & Development,Technology and platforms,Women's Health

    Neurogen biomarking virtual care ecosystem cuts time to Alzheimer’s intervention by 4.5 years

    New data presented at the Alzheimer’s Association International Conference 2025 [...]

    August 4, 2025
  • Clinical Trials,Global health,Partnerships & Funding,Precision medicine,Research & Development,Technology and platforms

    Phase 1 trial of novel HIV vaccine begins in Africa led by local researchers

    A new investigational HIV vaccine candidate, GRAdHIVNE1, has entered Phase [...]

    August 6, 2025
  • Clinical Development,Precision medicine,Rare Diseases,Real world evidence,Research & Development,Technology and platforms

    Nautilus and the Allen Institute partner to map tau proteoforms in Alzheimer’s disease research

    Nautilus Biotechnology has announced a new collaboration with the Allen [...]

    August 4, 2025
  • Artificial Intelligence,Technology and platforms

    Retab launches developer-first document AI platform and raises $3.5M in pre-seed funding

    Retab, a startup aiming to simplify document automation for developers, [...]

    July 30, 2025
  • Clinical Trials,Technology and platforms

    Cytovale’s IntelliSep rapid sepsis test boosts ED discharges by 56% while maintaining patient safety

    A new multicenter study shows Cytovale’s rapid sepsis test IntelliSep [...]

    July 31, 2025
  • Precision medicine,Research & Development,Technology and platforms

    New England Biolabs launches low-bias small RNA library prep kit to improve RNA sequencing accuracy

    New England Biolabs (NEB) has introduced the NEBNext Low-bias Small [...]

    July 29, 2025
  • Clinical Development,Global health,Patient Centricity,Real world evidence,Research & Development,Technology and platforms

    Cytovale’s IntelliSep test drives 56% rise in safe ED discharges, easing pressure on hospital beds

    A new multicenter study has found that a rapid blood [...]

    July 28, 2025
  • Market Access & Commercialization,Patient Centricity,Technology and platforms

    Pharma’s digital reckoning: Why SEO is now a strategic imperative

    With growing debate over a potential ban on DTC TV [...]

    July 29, 2025
  • Clinical Development,Drug Development,Precision medicine,Research & Development,Technology and platforms

    AltPep data highlights potential of intranasal peptide for early-stage Alzheimer’s

    AltPep Corporation has presented new preclinical findings at the Alzheimer’s [...]

    July 28, 2025
Previous161718Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • BridgeBio submits FDA NDA for BBP-418 in limb-girdle muscular dystrophy type 2I/R9
    Categories: Clinical Development, Drug Development, FDA, Genetic Diseases, Orphan drugs, Pharmaceuticals and therapeutics, Rare Diseases
  • Symeres and Ambagon partner on molecular glue research in colorectal cancer
    Categories: Drug discovery, Oncology, Partnerships & Funding, Research & Development, Startups and innovations, Technology and platforms
  • Insilico Medicine signs $2.75bn AI drug discovery deal with Eli Lilly
    Categories: Artificial Intelligence, Drug discovery, Partnerships & Funding
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top